Difference between revisions of "Spironolactone bodies"
Jump to navigation
Jump to search
(→Images) |
|||
Line 17: | Line 17: | ||
Image:Spironolactone_bodies_high_mag.jpg | SB - high mag. (WC/Nephron) | Image:Spironolactone_bodies_high_mag.jpg | SB - high mag. (WC/Nephron) | ||
Image:Spironolactone_bodies.png | SB (circled) - cropped high mag. (WC/Nephron) | Image:Spironolactone_bodies.png | SB (circled) - cropped high mag. (WC/Nephron) | ||
Image:Adrenal CorticalAdenoma SpironolactoneBodies MP PA.JPG|Adrenal Cortical Adenoma - Spironolactone Bodies (SKB) | |||
Image:Adrenal HyperplasticNodule SpironolactoneBodies MP PA.JPG|Adrenal Nodular Hyperplasia - Spironolactone Bodies (SKB) | |||
</gallery> | </gallery> | ||
Revision as of 11:46, 5 March 2015
Spironolactone bodies are seen in the cortex of the adrenal gland in the context of long-term spironolcatone use.
General
Etiology:
- Long-term use of spironolactone.
Note:
- Spironolactone is a commonly used anti-hypertensive medication.[1]
Microscopic
Features:[2]
- Location: zona glomerulosa (where aldosterone is produced).
- Appearance: eosinophilic spherical laminated whorls.
Images
See also
References
- ↑ Patel, KA.; Calomeni, EP.; Nadasdy, T.; Zynger, DL. (Aug 2014). "Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings.". Diagn Pathol 9 (1): 147. doi:10.1186/1746-1596-9-147. PMID 25108298.
- ↑ Kovacs K, Horvath E, Singer W (December 1973). "Fine structure and morphogenesis of spironolactone bodies in the zona glomerulosa of the human adrenal cortex". J. Clin. Pathol. 26 (12): 949-57. PMC 477936. PMID 4131694. http://jcp.bmj.com/cgi/pmidlookup?view=long&pmid=4131694.